Full Text View
Tabular View
No Study Results Posted
Related Studies
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
This study has been completed.
Study NCT00291720   Information provided by University Hospital Birmingham
First Received: February 13, 2006   Last Updated: May 20, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Cardiovascular Disease
Additional conditions recognized in this trial
Cardiovascular Diseases
Kidney Diseases
Kidney Failure
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Spironolactone
Placebo
More general drug interventions related to this trial
Aldosterone Antagonists
Cardiovascular Agents
Diuretics
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Natriuretic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University Hospital Birmingham
British Heart Foundation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services